Fetal Brain Care: Therapies for Brain Neurodevelopment in Fetal Growth Restriction

Recruiting N/A Interventional Study
Fetal Growth Retardation Intrauterine Growth Restriction
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Prevention
Participants needed
304 (estimated)
Sponsor
Institut d'Investigacions Biomèdiques August Pi i Sunyer · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Singleton pregnancies being diagnosed of fetal growth restriction from 24 to 32.6 weeks of gestation will be randomized to two equally sized groups: maternal oral supplementation with Lactoferrin and DHA (Docosahexaenoic acid) or placebo.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Singleton pregnancies * Non-malformed fetus * Pregnancies with fetal growth restriction * 24-32.6 weeks of gestation Exclusion Criteria: * Chromosomal or structural abnormalities diagnosed during pregnancy or in the neonatal period * Critical Doppler study suggesting the nee…
Contacts

Elisenda Eixarch, MD; PhD

0034 932279333

eixarch@clinic.cat

CONTACT

Elena Monterde, MD

0034 932279333

monterde@clinic.cat

CONTACT